Mycobacterium fortuitum is a rapidly growing Mycobacterium species that is a rare cause of disease, primarily in immunocompromised patients. We present a very low birth weight preterm neonate who developed M. fortuitum bloodstream infection, where 16S rDNA sequencing allowed accurate identification. Cure was achieved by line removal and adjuvant combination treatment with amikacin, ciprofloxacin and clarithromycin.
From the *Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada; †Royal Women’s Hospital, Melbourne, Victoria, Australia; ‡Department of Paediatrics, University of Toronto, §Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, and ¶Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Accepted for publication January 3, 2017.
Consent for publication was obtained from the child’s parent.
K.H. and S.I. contributed equally to this study.
The authors have no funding or conflicts of interest to disclose.
Address for correspondence: Kate Hodgson, MB BS, BMedSc, Royal Women's Hospital, 20 Flemington Rd, Parkville, Victoria 3052, Australia. E-mail: email@example.com.